Possible involvement of focal adhesion kinase, p125FAK, in osteoclastic bone resorption

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo.1993 · 89 citations
2. 2Identification and characterization of a novel cytoskeleton-associated pp60src substrate.1991 · 435 citations
3. 3Bombesin, vasopressin, and endothelin stimulation of tyrosine phosphorylation in Swiss 3T3 cells. Identification of a novel tyrosine kinase as a major substrate.1992 · 290 citations
4. 4Inhibition of osteoclastic motility by prostaglandins I₂, E₁, E₂ and 6‐oxo‐E₁1983 · 106 citations
5. 5Osteoclasts express high levels of p60^{c‐<i>src</i>}, preferentially on ruffled border membranes1992 · 87 citations